Global Microbiome Drug Development
R&D Funding
KRW 38.5B
Int'l Journals
197 Papers
Patents
55 Cases
Target-specific biomarker discovery, efficacy prediction, and high clinical success rates
Microbial
Resources
Genomic
DB
Machine
Learning
Medifood
Innovative
Drugs
ODA
Discovery of candidate functional materials
using the Pangenome Miner platform
Validation through
preclinical studies
Development of premium medifood
through human clinical trials
Commercialization of First-in-class innovative drugs
(Joint development & commercialization of
LBP with Global Big Pharma)